Earlier report suggested that phytosterol ester activated PPAR-α and PPAR-γ to treat NAFLD61 which was also well corroborated with the present study by using EECGL where phytosterol also present as an active compound to combat against HM induced NAFLD mediated systemic damage. The gene discussed is PPARG; the disease is metabolic dysfunction-associated steatotic liver disease.